Chest
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedberg, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedberg, J. S.
(Chest. 1999;116:497S-499S.)
© 1999 American College of Chest Physicians

Clinical Presentation of Stage IIIA (N2) Non-small Cell Lung Cancer*

Role of Multimodality Therapy

Joseph S. Friedberg, MD

* Department of Surgery, University of Pennsylvania Medical Center, Philadelphia, PA.

Correspondence to: Joseph S. Friedberg, MD, University of Pennsylvania Medical Center, 3400 Spruce St, Philadelphia, PA 19104; e-mail: josephf{at}mail.med.upenn.edu

Neoadjuvant chemotherapy before surgical resection of locally advanced non-small cell lung cancer (NSCLC) has been shown to improve survival compared with surgery alone in several randomized clinical trials. A case report is presented describing the use of paclitaxel and carboplatin in a multimodality regimen for a patient with stage IIIA N2 NSCLC. Studies are ongoing to determine the optimal type and timing of chemotherapy.

Key Words: multimodality therapy • neoadjuvant chemotherapy • non-small cell lung cancer • stage IIIA N2 disease • surgery






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Chest Physicians.